Results 21 to 30 of about 24,441 (269)
Journal of Orofacial Sciences, 2023 Introduction: Chemerin is a multifunctional chemoattractant cytokine, encoded by RARRES2 gene. Its role in oral carcinogenesis is largely unexplored. Study was undertaken to evaluate the role of salivary chemerin as a potential biomarker in the early ...
Karthika Pradeep Susha, Rathy Ravindran
doaj +1 more source
Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias [PDF]
, 2010 [Abstract] Objective. Identify candidate SEBs (surrogate endpoint biomarkers) for premalignant trends in head and neck mucosa. Study design. Study, by qPCR (quantitative real-time polymerase chain reaction), the expression of COX-2, EGFR and p53 in 24 ...
Antón-Aparicio, Luis M. +6 more
core +2 more sources
Immunohistochemical Evaluation of EGFR Expression in Oral Dysplastic and Non-Dysplastic Leukoplakia [PDF]
Journal of Mashhad Dental School, 2023 Background: This study aimed to evaluate the expression of epidermal growth factor receptor (EGFR) in oral leukoplakia with and without dysplasia and normal mucosa by immunohistochemistry.Materials and Methods: In this study, 45 samples of oral ...
Nasrollah Saghravanian +3 more
doaj +1 more source
CO2 lasers in the management of potentially malignant and malignant oral disorders [PDF]
, 2012 The CO2 laser was invented in 1963 by Kumar Patel. Since the early 1970s, CO2 laser has proved to be an effective method of treatment for patients with several types of oral lesions, including early squamous cell carcinoma.
Hamdoon, Z, Hopper, C, Jerjes, W
core +1 more source
Critical Reviews in Oral Biology & Medicine, 1995 Leukoplakia has evolved as a clinico-pathologic concept over many years, with the current clinical designation being accepted worldwide. Reflective of the biology of leukoplakia is the concept of cellular atypia and epithelial dysplasia. Adding to a better understanding of leukoplakia in general has been the definition of relevant clinical subsets ...
openaire +2 more sources
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Research progress of oral hairy leukoplakia [PDF]
Kouqiang yixueOral hairy leukoplakia is an oral mucosal disease caused by Epstein-Barr virusinfection of oral squamous epithelial cells. Oral hairy leukoplakia presents as a non-removable, corrugated and wrinkled white plaque sometimes with hair-like projections ...
MO Longhui, LIANG Jing, WANG Jiongke, LIU Tiannan, ZENG Xin
doaj +1 more source
Immunoexpression of Podoplanin in Leukoplakia and Oral Squamous Cell Carcinoma and its Correlation with Survival: A Research Protocol [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Podoplanin (PDPN) is a well-conserved mucin-type transmembrane glycoprotein. According to various studies, podoplanin expression is seen in various human cancers and it also encourages the progression of the tumour.
Samiha Jameel Ahmed Khan +4 more
doaj +1 more source
Oral leukoplakia, the ongoing discussion on definition and terminology [PDF]
, 2015 In the past decades several definitions of oral leukoplakia have been proposed, the last one, being authorized by the World Health Organization (WHO), dating from 2005.
Van der Waal, Isaäc
core +5 more sources
Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia
Molecular Cancer, 2007 Background Oral leukoplakia is a precancerous change developed in the oral mucosa, and the mechanism that oral leukoplakia becomes malignant through atypical epithelium is not known.
Hata Tsuyoshi +6 more
doaj +1 more source